Although exosome therapy is one of the most exciting innovations in regenerative medicine, it is not the first option for every type of sexual dysfunction. Proper patient selection is essential for the success of this advanced treatment. Clinical criteria and suitable candidate groups regarding who is eligible for exosome therapy in andrology are detailed in this article.
Most Suitable Candidates for Exosome Therapy
Exosome injections are typically planned in the following clinical scenarios:
- Refractory Erectile Dysfunction: Patients with vascular erectile dysfunction who do not benefit from medical therapy (performance medication) or cannot use medication due to side effects.
- Diabetic and Hypertensive Patients: Men with significant damage to penile blood vessels and nerves due to diabetes or hypertension.
- Post-Prostate Cancer Surgery Patients: Patients who have lost erectile function due to cavernous nerve injury following radical prostatectomy (success rates are significantly higher if nerve-sparing surgery was performed).
- Peyronie's Disease Patients: Patients with palpable hard fibrotic plaques in the penis seeking non-surgical, painless recovery.
- Men Seeking to Delay Sexual Aging: Men experiencing age-related loss of penile tissue elasticity and volume who wish to maintain sexual vitality.
Following a comprehensive andrological evaluation, the patient's hormonal profile and vascular anatomy (via Penile Doppler Ultrasound) are analyzed to determine eligibility for exosome therapy.